PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
22532603-6	2012	The proteasome inhibitor bortezomib blocked NF-kappaB activity, decreased phospho-ERK1/2, increased phospho-c-jun-NH(2)-kinase (p-JNK) levels, reduced expression of resistance factors, restored MART-1 expression to sufficient levels, which in combination allowed M244R lines be sensitized to F5 CTL killing.	Bortezomib	25-35	mitogen-activated protein kinase 8	Homo sapiens	130-133